Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01825135 · ClinicalTrials.gov registry record · NA

Electrical Stimulation to Strengthen Muscles in the Lower Legs in Patients Requiring Prolonged Mechanical Ventilation

A NA study of Muscle Weakness, sponsored by RML Specialty Hospital.

Completed
Registry status
NA
Development phase
57
Enrollment target
1
Study location

NCT01825135: Completed NA study of Muscle Weakness, sponsored by RML Specialty Hospital.

NCT01825135 is a NA study of Muscle Weakness that has completed, run by RML Specialty Hospital. The registered enrollment target is 57 participants, below the 73-participant average among 25 other Muscle Weakness trials with a reported enrollment target (22% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01825135, a NA study of Muscle Weakness, has completed, sponsored by RML Specialty Hospital.

COMPLETED
Registry status
NA
Development phase
57 participants
Enrollment target
1
Study location

Study Summary

The primary aim of this proposal is to test the effectiveness of NMES in improving functional status and muscle function in patients requirng prolonged mechanical ventilation

Primary Outcome

Functional status as measured by modified Functional Independence Measurement (FIM) score

Conditions Studied

Interventions

  • DEVICE sham stimulation
  • DEVICE Neuromuscular electrical stimulation

Study Locations (1)

Illinois

  • RML Specialty Hospital - Hinsdale

Trial Details

FieldValue
Enrollment Target 57 participants
Start Date 2011-03
Est. Completion 2016-08
Phase NA
RML Specialty Hospital

2 total trials

What the finished NCT01825135 record still lists

NCT01825135 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 57 participants, a relatively small participant target, below the 73-participant average among 25 other Muscle Weakness trials with a reported enrollment target (22% lower).

The record links to 1 condition, with Muscle Weakness appearing as the primary indexed condition, and to 2 interventions - of which sham stimulation is the first listed.

NCT01825135 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT01825135 about?

NCT01825135 is a clinical study titled "Electrical Stimulation to Strengthen Muscles in the Lower Legs in Patients Requiring Prolonged Mechanical Ventilation". The primary aim of this proposal is to test the effectiveness of NMES in improving functional status and muscle function in patients requirng prolonged mechanical ventilation

What is the current status of trial NCT01825135?

This trial is currently completed. It is a NA study. The enrollment target is 57 participants. The study started on 2011-03. Estimated completion is 2016-08.

What conditions does trial NCT01825135 study?

This clinical trial studies the following conditions: Muscle Weakness.

What interventions are being tested in trial NCT01825135?

The interventions under investigation include: sham stimulation (DEVICE), Neuromuscular electrical stimulation (DEVICE).

Who is sponsoring clinical trial NCT01825135?

This trial is sponsored by RML Specialty Hospital, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01825135 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Muscle Weakness

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01825135's enrollment target sits among peer trials

57 15th of 25 higher than 11 of 25 other Muscle Weakness trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Muscle Weakness trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03521830 · 57 participants · Phase 2

    Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma

  • NCT03587701 · 57 participants · Phase 2

    Effects of Anakinra in Subjects With Corticosteroid-resistant/Intolerant Meniere's Disease and Autoimmune Inner Ear Disease

  • NCT04104126 · 57 participants · NA

    Blood Flow Restriction Therapy in Achilles Injury

  • NCT04703842 · 57 participants · Phase 1

    Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01825135, the US trial registry maintained by the National Library of Medicine. NCT01825135 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.